Access to enclomiphene is being reshaped by new delivery models. Polaris Market Research values the enclomiphene market at USD 231.4 million in 2026, rising to USD 445.8 million by 2034 at a CAGR of 8.5%. Products reach consumers through physician-led hormone optimization therapies, pharmacies and digital healthcare platforms, and the value chain spans API manufacturers, formulation...